Work

Abstract 5852: A novel CD33 and TRAIL-R2 targeting bispecific antibody to treat relapsed/refractory acute myeloid leukemia

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-5852

Authors: Shiva Bhowmik, William Brady, Kaitlyn Ko, Sheng Cai, William Grossman, Naval Daver, Jonathan Gerber, Herbert Kim Lyerly

Institutions: Purdue University West Lafayette, University of Washington, Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, Johns Hopkins University, Duke University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148706332

Cites:

Cited by:

Related to: